Buy PeptidesReference compendium
Search

About / Peptides / Liraglutide

Weight research

Liraglutide

Anti-diabetic medication

  • FormulaC172H265N43O51
  • Molecular weight3751 g/mol
  • CAS number204656-20-2
  • PubMed results5,656

Reference sheet 22 of 40Data retrieved 2026-10-08.PubChem · PubMed · Wikipedia

Identification

Field of researchWeight research
FormulaC172H265N43O51
Molecular weight3751 g/mol
CAS number204656-20-2
Also known asvictoza, NN2211, Liraglutida, Liraglutidum, Saxenda, NN-2211, Liraglutide recombinant, NNC 90-1170, Liraglutide (rDNA origin), NNC-90-1170
PubChemCID 16134956

Summary

Liraglutide, sold under the brand name Victoza among others, is an anti-diabetic medication used to treat type 2 diabetes, and chronic obesity.

From Wikipedia, available under CC BY-SA 4.0. Short description from Wikidata (CC0).

Published research

Titles are shown as published. Listing a paper is not an endorsement of its findings, and many papers on research peptides are laboratory or animal studies: the type of study is shown when PubMed records it.

  1. Liraglutide and Cardiovascular Outcomes in Type 2 DiabetesMulticenter StudyRandomized Controlled TrialResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tMarso SP, Daniels GH, Brown-Frandsen K et al. · N Engl J Med, 2016 · PMID 27295427 · DOI
  2. The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight lossResearch Support, Non-U.S. Gov'tSecher A, Jelsing J, Baquero AF et al. · J Clin Invest, 2014 · PMID 25202980 · DOI
  3. Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK/ACC signaling and inhibiting ferroptosisResearch Support, Non-U.S. Gov'tGuo T, Yan W, Cui X et al. · Mol Med, 2023 · PMID 37770820 · DOI
  4. Liraglutide Promotes Diabetic Wound Healing via Myo1c/Dock5Research Support, Non-U.S. Gov'tZhang Q, Zhang C, Kang C et al. · Adv Sci (Weinh), 2024 · PMID 39159301 · DOI
  5. Empagliflozin and liraglutide ameliorate HFpEF in mice via augmenting the Erbb4 signaling pathwayNi XY, Feng XJ, Wang ZH et al. · Acta Pharmacol Sin, 2024 · PMID 38589689 · DOI
  6. Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical TrialMulticenter StudyRandomized Controlled TrialResearch Support, Non-U.S. Gov'tDavies MJ, Bergenstal R, Bode B et al. · JAMA, 2015 · PMID 26284720 · DOI
  7. LiraglutideStudy GuideCerillo JL, Parmar M · 2024 · PMID 39383283
  8. Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized TrialClinical Trial, Phase IIIMulticenter StudyRandomized Controlled TrialMathieu C, Zinman B, Hemmingsson JU et al. · Diabetes Care, 2016 · PMID 27506222 · DOI

Top 8 of 5,656 results, by relevance. See all on PubMed.

Search query "Liraglutide"[Title/Abstract]

Data provenance

DataSourceRecord
Chemical identity and structurePubChemCID 16134956
Published literaturePubMedSearch on PubMed
Summary sentenceWikipediaLiraglutide

Data retrieved 2026-10-08. See About for the sources. How the data is collected and checked: Methods.